anurajms/meta_analysis huggingface dataset:
Interventions:
Surgical versus non‐surgical interventions for treating patellar dislocation
1. Reconstruction Of Medial Collateral Ligament Of Knee Joint 2. Lateral Release Of Contracture Of Knee Joint 3. Reefing Of Bone 4. Repair Of Recurrent Dislocation Of Patella 5. Quadricepsplasty 6. Trochanterplasty 7. Patellaplasty 8. Reconstruction Of Dislocating Patella With Patellectomy 9. Bone Reconstruction 10. Repair Of Ligament 11. Ligament Reconstruction
Interventions:
Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia
1. Vitamin D and analogues
Interventions:
Bisphosphonates for osteoporosis in people with cystic fibrosis
1. Bisphosphonates
Interventions:
Glucocorticoids for croup in children
1. Glucocorticoids - Systemic
Interventions:
Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants
1. Paracetamol
Interventions:
Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants
1. Corticosteroids - Opthamological and Otological 2. Inhaled
Interventions:
Vaccines for the common cold
1. Preventive 2. Vaccine
Interventions:
Homeopathic medicinal products for preventing and treating acute respiratory tract infections in children
1. Homeopathic Therapy 2. Oral
Interventions:
Interventions for the eradication of meticillin‐resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
1. Antibacterials For Systemic Use
Interventions:
Family‐centred interventions for Indigenous early childhood well‐being by primary healthcare services
1. Family-centred care
Interventions:
Ultrasound guidance versus landmark method for peripheral venous cannulation in adults
1. Ultrasonic Guidance Procedure
Interventions:
Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb
1. Peripheral Neuroanastomosis 2. Artificial Conduit 3. Nerve Wrap
Interventions:
Statins for Smith‐Lemli‐Opitz syndrome
1. Bile acid supplementation 2. Lipohilic statins 3. Hydrophilic statins 4. Statin Prophylaxis
Interventions:
Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis
1. Anti-bacterial agent 2. Inhaled
Interventions:
Pharmacological interventions for pain and sedation management in newborn infants undergoing therapeutic hypothermia
1. Alpha-2 adrenergic agonists 2. Analgesics 3. NMDA receptor antagonist 4. Opioids 5. Sedative
Interventions:
Support for healthy breastfeeding mothers with healthy term babies
1. Breastfeeding Support
Interventions:
Biomarkers as point‐of‐care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care
1. Biomarker analysis
Interventions:
Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis
1. Golimumab 2. Certolizumab Pegol 3. Infliximab 4. Etanercept 5. Adalimumab
Interventions:
Splinting for the non‐operative management of developmental dysplasia of the hip (DDH) in children under six months of age
1. Static Splinting 2. Infant Nappy 3. Dynamic Splinting
Interventions:
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
1. Corticosteroids - Inhaled
Interventions:
Laser therapy for treating hypertrophic and keloid scars
1. Laser therapy
Interventions:
Appetite stimulants for people with cystic fibrosis
1. Appetite Stimulants
Interventions:
Synbiotics, prebiotics and probiotics for solid organ transplant recipients
1. Probiotics 2. Synbiotics 3. Prebiotics
Interventions:
Fluvoxamine for the treatment of COVID‐19
1. Usual Care 2. Fluvoxamine
Interventions:
Water for wound cleansing
1. Water
Interventions:
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients
1. Immunosuppressive Therapy 2. Treatment-adherence therapy
Interventions:
Adding rapid diagnostic tests to community‐based programmes for treating malaria
1. Training 2. Antimalarial 3. Malaria rapid diagnostic test
Interventions:
Stiripentol add‐on therapy for drug‐resistant focal epilepsy
1. Stiripentol 2. Antiepileptics
Interventions:
D‐mannose for preventing and treating urinary tract infections
1. Preventive 2. Mannose
Interventions:
Strategies for enhancing the implementation of school‐based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use
1. Health Promotion 2. Fiscal Resource Management 3. Institutional Environmental Intervention 4. Health Plan Implementation 5. Program Evaluation
Interventions:
Memantine for autism spectrum disorder
1. Memantine
Interventions:
Probiotics for preventing acute upper respiratory tract infections
1. Preventive 2. Probiotics
Interventions:
Psychological therapies for temporomandibular disorders (TMDs)
1. Behavioral Therapy 2. Cognitive Behavioral Therapy
Interventions:
Physical activity and exercise training in cystic fibrosis
1. Physical therapy exercises
Interventions:
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
1. Antibiotic Therapy 2. Inhaled
Interventions:
Anti‐IL‐5 therapies for asthma
1. Interleukin-5 Inhibitor
Interventions:
Child protection training for professionals to improve reporting of child abuse and neglect
1. Child Abuse Prevention
Interventions:
Short‐acting inhaled bronchodilators for cystic fibrosis
1. Terbutaline 2. Inhaled Bronchodilator Therapy 3. Fenoterol 4. Salbutamol 5. Ipratropium Bromide
Interventions:
Exercise versus airway clearance techniques for people with cystic fibrosis
1. Active Cycle Of Breathing Technique 2. Autogenic Pulmonary Drainage 3. Exercise therapy 4. Oscillatory device 5. Postural Drainage Therapy 6. Positive End Expiratory Pressure Therapy
Interventions:
Interventions to improve water, sanitation, and hygiene for preventing soil‐transmitted helminth infection
1. Water quality improvement 2. Hygiene Education 3. Provision Of Adequate Water Supply 4. Sanitation measures
Interventions:
Non‐pharmacological interventions for sleep promotion in hospitalized children
1. Non-Pharmacological Interventions
Interventions:
Digital interventions to improve adherence to maintenance medication in asthma
1. Digital intervention
Interventions:
Antibiotics for the induction and maintenance of remission in ulcerative colitis
1. Intravenous 2. Oral 3. Antibiotic Therapy
Interventions:
Community‐based interventions for improving mental health in refugee children and adolescents in high‐income countries
1. Family Support 2. Coping Support 3. Cognitive Behavioral Therapy
Interventions:
Music therapy for autistic people
1. Music Therapy 2. Usual Care
Interventions:
Care delivery and self‐management strategies for children with epilepsy
1. Neurological care
Interventions:
Probiotics for the prevention of Hirschsprung‐associated enterocolitis
1. Probiotics
Interventions:
Negative pressure wound therapy for surgical wounds healing by primary closure
1. Negative Pressure Wound Therapy 2. Suction System 3. Negative Pressure Wound Dressing
Interventions:
Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron and iodine status
1. Double fortified salt
Interventions:
Continuous positive airway pressure (CPAP) for acute bronchiolitis in children
1. Continuous Positive Airway Pressure Ventilation
Interventions:
Prophylactic cyclo‐oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta‐analysis
1. Paracetamol 2. Ibuprofen 3. Prophylaxis 4. Indomethacin
Interventions:
Probiotics for treatment of chronic constipation in children
1. Probiotics
Interventions:
Unconditional cash transfers for reducing poverty and vulnerabilities: effect on use of health services and health outcomes in low‐ and middle‐income countries
1. Cash Transfer 2. Lower Middle Income Country 3. Unconditional cash transfer
Interventions:
Oral dextrose gel for the treatment of hypoglycaemia in newborn infants
1. Glucose 2. Oral
Interventions:
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
1. Vitamin A 2. Oral
Interventions:
Systemic interventions for treatment of Stevens‐Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome
1. Systemic
Interventions:
Synbiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants
1. Synbiotics
Interventions:
Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
1. Extended release 2. Methylphenidate
Interventions:
Clonazepam monotherapy for treating people with newly diagnosed epilepsy
1. Clonazepam
Interventions:
Sealants for preventing dental caries in primary teeth
1. Dental Pit/Fissure Sealant
Interventions:
Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years
1. Occlusion Therapy
Interventions:
Antiepileptic drugs for the primary and secondary prevention of seizures after stroke
1. Antiepileptics
Interventions:
Low‐carbohydrate versus balanced‐carbohydrate diets for reducing weight and cardiovascular risk
1. Weight reduction regime 2. Low carbohydrate diet
Interventions:
Cuffed versus uncuffed endotracheal tubes for neonates
1. Endotracheal Tube Cuff Inflator 2. Endotracheal Tube Cuff 3. Endotracheal Tube
Interventions:
Oral antihistamine‐decongestant‐analgesic combinations for the common cold
1. Decongestants And Other Nasal Preparations For Topical Use 2. Analgesics 3. Nasal Decongestants For Systemic Use 4. Antihistamine
Interventions:
Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants
1. Enteral nutrition 2. Parenteral nutrition
Interventions:
Rapid versus slow withdrawal of antiepileptic drugs
1. Medication Withdrawal
Interventions:
Intermittent prophylactic antibiotics for bronchiectasis
1. Antibacterials For Systemic Use 2. Intermittent Administration 3. Prophylaxis
Interventions:
Orthodontic treatment for crowded teeth in children
1. Fixed Appliance Therapy 2. Tooth Extraction 3. Removable Orthodontic Appliance
Interventions:
Orthodontic treatment for posterior crossbites
1. Orthodontic Appliance
Interventions:
Interventions for treating distal intestinal obstruction syndrome (DIOS) in cystic fibrosis
1. Mucolytic 2. Drugs For Constipation 3. Procedure On Intestine 4. Laxative
Interventions:
Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis
1. Preventive 2. Laxative
Interventions:
Transfusion thresholds for guiding red blood cell transfusion
1. Transfusion Using High Hemoglobin Threshold 2. Red Blood Cell Transfusion 3. Transfusion Using Low Hemoglobin Threshold
Interventions:
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
1. Continuous blood glucose monitoring
Interventions:
Peer support interventions for parents and carers of children with complex needs
1. Peer support
Interventions:
Nifedipine for primary dysmenorrhoea
1. Nifedipine
Interventions:
Autogenic drainage for airway clearance in cystic fibrosis
1. Autogenic Pulmonary Drainage
Interventions:
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis
1. Oral 2. Antibiotic Therapy 3. Inhaled
Interventions:
Chemotherapy for second‐stage human African trypanosomiasis: drugs in use
1. Fexinidazole 2. NECT 3. Acoziborole.
Interventions:
Antibiotics for treatment of sore throat in children and adults
1. Antibiotic Therapy
Interventions:
Pharmacological treatment for psychotic depression
1. Antipsychotics 2. Antidepressants
Interventions:
Carisbamate add‐on therapy for drug‐resistant focal epilepsy
1. Carisbamate 2. Antiepileptics
Interventions:
Parenteral versus enteral fluid therapy for children hospitalised with bronchiolitis
1. Enteral nutrition 2. Fluid therapy
Interventions:
Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline
1. Antioxidants 2. Green Tea Extract 3. Coenzyme Q10 4. Acetylcysteine 5. Idebenone 6. Citrulline 7. Metformin
Interventions:
Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants
1. Continuous Positive Airway Pressure Ventilation
Interventions:
Topiramate for juvenile myoclonic epilepsy
1. Topiramate
Interventions:
Non‐corticosteroid adjuvant therapies for acute bacterial meningitis
1. Adjuvant 2. Antibiotic Therapy
Interventions:
Vaccines for measles, mumps, rubella, and varicella in children
1. Measles-mumps-rubella Vaccination
Interventions:
Macrolides versus placebo for chronic asthma
1. Macrolides
Interventions:
Vitamin C supplementation for prevention and treatment of pneumonia
1. Preventive 2. Vitamin C 3. Drug Therapy
Interventions:
Vaccines for preventing rotavirus diarrhoea: vaccines in use
1. Rotavirus Vaccination
Interventions:
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children
1. Palivizumab
Interventions:
Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
1. Corticosteroids - Opthamological and Otological
Interventions:
Decision coaching for people making healthcare decisions
1. Decision coaching
Interventions:
Antiepileptic drugs for seizure control in people with neurocysticercosis
1. Anthelmintic 2. Anabolic Steroids 3. Antiepileptics
Interventions:
Phototherapy for atopic eczema
1. Light Therapy
Interventions:
Intermittent catheter techniques, strategies and designs for managing long‐term bladder conditions
1. Urinary Catheter 2. Sterile Urethral Catheters 3. Implementation Of Aseptic Technique 4. Hydrophilic-coated catheter
Interventions:
Avoidance of bottles during the establishment of breastfeeds in preterm infants
1. Enteral+supplement Feeds 2. Cup 3. Breastfeeding 4. Dropper 5. Spoon
Interventions:
Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
1. Corticosteroids - Nasal preparations 2. Intravenous 3. Oral
Interventions:
Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
1. Interleukin-4 Inhibitor 2. Interleukin-13 Inhibitor
Interventions:
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants
1. Nasal 2. Prophylaxis 3. Continuous Positive Airway Pressure Ventilation
Interventions:
Provision of folic acid for reducing arsenic toxicity in arsenic‐exposed children and adults
1. Folic Acid 2. Folate Fortified Food 3. Nutritional supplement 4. Other Nutrients
Interventions:
Materials for retrograde filling in root canal therapy
1. Root Canal Filling Material
Interventions:
Pharmacotherapy for trichotillomania
1. Drug Therapy
Interventions:
Sulthiame monotherapy for epilepsy
1. Sulthiame
Interventions:
Treatments for seizures in catamenial (menstrual‐related) epilepsy
1. Antiepileptics 2. Hormone Therapy
Interventions:
Non‐pharmacological interventions for stuttering in children six years and younger
1. Non-Pharmacological Interventions
Interventions:
Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD)
1. Cognitive Behavioral Therapy 2. Behavioral Therapy
Interventions:
Vitamin D supplementation for chronic liver diseases in adults
1. Calcium 2. Vitamin D and analogues
Interventions:
Recombinant growth hormone therapy for cystic fibrosis in children and young adults
1. Somatropin
Interventions:
Heliox for croup in children
1. Oxygen 2. Helium 3. Inhaled
Interventions:
Chloral hydrate as a sedating agent for neurodiagnostic procedures in children
1. Chloral Hydrate
Interventions:
Direct composite resin fillings versus amalgam fillings for permanent posterior teeth
1. Restoration, Resin
Interventions:
Continuous versus bolus intermittent intragastric tube feeding for preterm and low birth weight infants with gastro‐oesophageal reflux disease
1. Continuous Enteral Tube Feeding 2. Orogastric Feeding 3. Nasogastric Feeding
Interventions:
Push versus gravity for intermittent bolus gavage tube feeding of preterm and low birth weight infants
1. Tube Feeding By Syringe Method
Interventions:
Timing of pancreatic enzyme replacement therapy (PERT) in cystic fibrosis
1. Pancreatic enzyme
Interventions:
Schedules for home visits in the early postpartum period
1. Home Visit For Postpartum Care And Assessment
Interventions:
Opioid treatment for opioid withdrawal in newborn infants
1. Opioids
Interventions:
Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates
1. Light Therapy 2. Sun Exposure
Interventions:
Bisphosphonate use in children with cerebral palsy
1. Bisphosphonates
Interventions:
Ivermectin treatment in humans for reducing malaria transmission
1. Ivermectin
Interventions:
Altered dietary salt intake for people with chronic kidney disease
1. Recommendation To Change Sodium Intake
Interventions:
Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams
1. Infant Formula 2. Continuous Enteral Tube Feeding 3. Breast Milk 4. Nasogastric Feeding
Interventions:
Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
1. Eslicarbazepine 2. Adjuvant
Interventions:
Prophylactic drug management for febrile seizures in children
1. Administration Of Antipyretic 2. Benzodiazepine 3. Antiepileptics 4. Zinc
Interventions:
Oral antibiotics for chronic blepharitis
1. Oral Antibiotic Therapy 2. Corticosteroids - Opthamological and Otological 3. Doxycycline
Interventions:
Topical azole treatments for otomycosis
1. Azole antifungal 2. Topical
Interventions:
New generation antidepressants for depression in children and adolescents: a network meta‐analysis
1. Antidepressants
Interventions:
Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa
1. Piperonyl Butoxide 2. Mosquito Nets
Interventions:
Internet‐based cognitive and behavioural therapies for post‐traumatic stress disorder (PTSD) in adults
1. Therapist-supported Internet Cognitive-Behavioral Therapy 2. Internet-delivered Cognitive Behavioural Therapy
Interventions:
Sedatives for opioid withdrawal in newborn infants
1. Analgesics 2. Hypnotics And Sedatives
Interventions:
Antibiotic regimens for early‐onset neonatal sepsis
1. Antibiotic Therapy
Interventions:
Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma
1. Histamine H2 Receptor Antagonist Prophylaxis 2. Proton Pump Inhibitors 3. Surgery 4. Prokinetic Agent 5. Antacid
Interventions:
Rubber dam isolation for restorative treatment in dental patients
1. Restorative dental procedure 2. Dental Rubber Dam
Interventions:
Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome
1. Surfactant
Interventions:
Topical emollient for preventing infection in preterm infants
1. Emollients And Protectives 2. Administration Of Drug Or Medicament To Skin Via Topical Route
Interventions:
Paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries
1. Pay for Perfomance
Interventions:
Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
1. Antiepileptics
Interventions:
Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection
1. Antimicrobial Susceptibility Test
Interventions:
Drug therapies for reducing gastric acidity in people with cystic fibrosis
1. Proton Pump Inhibitors 2. H2-receptor Antagonists 3. Drug Therapy
Interventions:
Cough augmentation techniques for people with chronic neuromuscular disorders
1. Breath Stacking 2. Mechanically-assisted Cough 3. Therapeutic Insufflation 4. Breathing Exercises 5. Cough Augmentation Techniques 6. Manually-assisted Cough 7. Airstacking 8. Diaphragmatic Breathing Exercises 9. Encouragement Of Deep Breathing And Coughing Exercises
Interventions:
Antidepressants for people with epilepsy and depression
1. Antidepressants 2. Antiepileptics
Interventions:
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
1. Corticosteroids - Inhaled 2. Formoterol
Interventions:
Anti‐seizure medications for Lennox‐Gastaut syndrome
1. Homeopathic Therapy 2. Antiepileptics 3. Acupuncture
Interventions:
Circumcision devices versus standard surgical techniques in adolescent and adult male circumcisions
1. Device-based circumcision
Interventions:
Lung recruitment manoeuvres for reducing mortality and respiratory morbidity in mechanically ventilated neonates
1. Recruitment Manoeuvre
Interventions:
Dornase alfa for cystic fibrosis
1. Dornase Alfa
Interventions:
Opioids for newborn infants receiving mechanical ventilation
1. Opioids
Interventions:
Zinc supplementation for improving pregnancy and infant outcome
1. Zinc
Interventions:
Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates
1. Zinc supplement 2. Usual Care
Interventions:
High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants
1. Enteral nutrition 2. High Dose
Interventions:
Timing of dornase alfa inhalation for cystic fibrosis
1. Recombinant Human Dnase 2. Inhaled
Interventions:
Interventions for self‐harm in children and adolescents
1. Drug Therapy 2. Psychotherapy
Interventions:
High‐flow nasal cannulae for respiratory support in adult intensive care patients
1. Nasal 2. Humidified Oxygen Therapy 3. High Flow Oxygen Nasal Cannula
Interventions:
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus
1. Ultra-long-acting insulin analogue 2. Long-acting insulin 3. Biosimilar insulin
Interventions:
Interventions for bacterial folliculitis and boils (furuncles and carbuncles)
1. Incision 2. Antiseptics 3. Topical 4. Systemic 5. Drainage Procedure 6. Antibiotic Therapy 7. Phototherapy Of Skin
Interventions:
Antibiotics to prevent complications following tooth extractions
1. Antibiotic Prophylaxis 2. Systemic
Interventions:
Patient and lay carer education for preventing pressure ulceration in at‐risk populations
1. Caregiver Education 2. Patient Education
Interventions:
Fluid restriction in the management of transient tachypnea of the newborn
1. Fluid Restriction
Interventions:
The effectiveness and adverse effects of D‐cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder
1. Cycloserine
Interventions:
Topical versus systemic antibiotics for chronic suppurative otitis media
1. Topical 2. Antibiotic Therapy
Interventions:
Salbutamol for transient tachypnea of the newborn
1. Salbutamol
Interventions:
Systemic antibiotics for chronic suppurative otitis media
1. Systemic 2. Antibiotic Therapy
Interventions:
Urgent‐start peritoneal dialysis versus haemodialysis for people with chronic kidney disease
1. Peritoneal Dialysis
Interventions:
Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
1. Beta Blocking Agent
Interventions:
Surgical interventions for the early management of Bell's palsy
1. Early Treatment 2. Surgery
Interventions:
Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
1. Band Ligator
Interventions:
Effect of atorvastatin on testosterone levels
1. Atorvastatin
Interventions:
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents
1. Ethosuximide 2. Valproate 3. Lamotrigine
Interventions:
Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO‐defined non‐severe pneumonia and wheeze
1. Antibiotic Therapy
Interventions:
Interventions for treating iron deficiency anaemia in inflammatory bowel disease
1. Iron
Interventions:
Indomethacin for symptomatic patent ductus arteriosus in preterm infants
1. Indomethacin
Interventions:
Early full enteral feeding for preterm or low birth weight infants
1. Early Treatment 2. Enteral nutrition
Interventions:
Oral hygiene care for critically ill patients to prevent ventilator‐associated pneumonia
1. Mouthwash 2. Toothbrushing 3. Oral Hygiene Measures
Interventions:
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
1. Outpatient Environment 2. Parenteral 3. Oral 4. Anticoagulant therapy
Interventions:
Respiratory muscle training for cystic fibrosis
1. Respiratory Muscle Training
Interventions:
Magnesium sulphate for treating acute bronchiolitis in children up to two years of age
1. Magnesium Sulfate
Interventions:
Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age
1. Oral 2. Vitamin D and analogues 3. Nutrient supplementation
Interventions:
Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health
1. Vitamin D and analogues
Interventions:
Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants
1. Paracetamol 2. Early Treatment 3. Ibuprofen 4. Indomethacin
Interventions:
N‐acetylcysteine for non‐paracetamol (acetaminophen)‐related acute liver failure
1. Acetylcysteine
Interventions:
Interventions to increase patient and family involvement in escalation of care for acute life‐threatening illness in community health and hospital settings
1. Family Involvement Promotion 2. Patient participation
Interventions:
Probiotics for treating acute infectious diarrhoea
1. Probiotics
Interventions:
Pneumococcal conjugate vaccines for preventing acute otitis media in children
1. Preventive 2. Pneumococcal polysaccharide conjugated vaccine
Interventions:
Individualized versus standard diet fortification for growth and development in preterm infants receiving human milk
1. Human milk-based fortifier 2. Breast Milk
Interventions:
Comparison of different protein concentrations of human milk fortifier for promoting growth and neurological development in preterm infants
1. Fortified Milk 2. Protein Supplements 3. Breast Milk
Interventions:
Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy
1. Electromechanical-assisted Gait Training 2. Robotic-assisted Gait Training 3. Treadmill, Mechanical
Interventions:
Cognitive behavioural therapy for anxiety disorders in children and adolescents
1. Cognitive Behavioral Therapy
Interventions:
Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
1. Ligation Of Esophageal Varices
Interventions:
Rufinamide add‐on therapy for drug‐resistant epilepsy
1. Rufinamide 2. Antiepileptics
Interventions:
Pharmacological treatment for continuous spike‐wave during slow wave sleep syndrome and Landau‐Kleffner Syndrome
1. Antiepileptics
Interventions:
Pit and fissure sealants versus fluoride varnishes for preventing dental decay in the permanent teeth of children and adolescents
1. Dental Pit/Fissure Sealant 2. Application Of Dental Fluoride Varnish
Interventions:
Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea
1. Myofunctional Therapy
Interventions:
Specialised early intervention teams for recent‐onset psychosis
1. Community Mental Health Team 2. Early Treatment 3. Assessment By Multiprofessional Team
Interventions:
Specialised early intervention teams (extended time) for recent‐onset psychosis
1. Community Mental Health Team 2. Early Treatment 3. Assessment By Multiprofessional Team
Interventions:
Physical activity interventions for people with congenital heart disease
1. Exercise 2. Inspiratory Muscle Training 3. Promotion Of Adherence To Exercise Regime
Interventions:
Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy
1. Continuous Behavioral Assessment 2. Management of drug regimen 3. Patient Education 4. Care Provision Regime
Interventions:
Virtual reality distraction for acute pain in children
1. Distraction 2. Virtual Reality
Interventions:
Drug treatments for managing cystic fibrosis‐related diabetes
1. Insulins and analogues 2. Glycaemic-lowering agent
Interventions:
Early versus delayed continuous positive airway pressure (CPAP) for respiratory distress in preterm infants
1. Continuous Negative Pressure Ventilation Treatment 2. Continuous Positive Airway Pressure Ventilation
Interventions:
Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants
1. Continuous Negative Pressure Ventilation Treatment 2. Continuous Positive Airway Pressure Ventilation
Interventions:
Interventions to reduce contaminated aerosols produced during dental procedures for preventing infectious diseases
1. Decontamination 2. Room ventilation 3. Dental Rubber Dam
Interventions:
Prophylactic corticosteroids for paediatric heart surgery with cardiopulmonary bypass
1. Preventive 2. Steroid Prophylaxis
Interventions:
Household interventions for secondary prevention of domestic lead exposure in children
1. Lead 2. Maintaining A Safe Environment 3. Home Safety Education 4. Home
Interventions:
Branched‐chain amino acid supplementation for improving growth and development in term and preterm neonates
1. Branched Chain Amino Acid Supplementation
Interventions:
Pine bark (Pinus spp.) extract for treating chronic disorders
1. Pine Bark Extract
Interventions:
Protein supplementation of human milk for promoting growth in preterm infants
1. Protein Supplements 2. Breast Milk
Interventions:
Interventions for preventing ophthalmia neonatorum
1. Oxytetracycline 2. Povidone-iodine 3. Florfenicol / Sulfacetamide Ophthalmic Solution 4. Silver Nitrate 5. Tetracycline Ophthalmic Ointment 6. Penicillin 7. Erythromycin Ophthalmic Ointment 8. Chloramphenicol 9. Colostrum
Interventions:
Aural toilet (ear cleaning) for chronic suppurative otitis media
1. Ear Care 2. Microsuction cleaning of ear canal 3. Irrigation of ear 4. Cotton Bud
Interventions:
Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review
1. Quarantine
Interventions:
Systemic treatments for eczema: a network meta‐analysis
1. Systemic
Interventions:
Carbohydrate supplementation of human milk to promote growth in preterm infants
1. Carbohydrates 2. Breast Milk
Interventions:
Psychological and social interventions for the prevention of mental disorders in people living in low‐ and middle‐income countries affected by humanitarian crises
1. Preventive
Interventions:
Psychological treatments for people with epilepsy
1. Monitoring Adherence To Medication Regime 2. Psychological Assessment 3. Education Assistance 4. Self-care practice
Interventions:
Vitamin E supplementation in people with cystic fibrosis
1. Vitamin E
Interventions:
Hydrosurgical debridement versus conventional surgical debridement for acute partial‐thickness burns
1. Split Thickness Skin Graft
Interventions:
Pharmacotherapy for hyperuricaemia in hypertensive patients
1. Xanthine oxidase inhibitor 2. Uricosuric agent
Interventions:
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
1. Oral 2. Aminosalicylic Acid And Similar Agents
Interventions:
Surgical interventions for primary congenital glaucoma
1. Glaucoma surgery
Interventions:
Interventions for American cutaneous and mucocutaneous leishmaniasis
1. Intralesional Injection 2. Allopurinol 3. Azithromycin 4. Granulocyte-macrophage Colony Stimulating Factors 5. Antimony Compounds 6. Pentamidine 7. Vaccine 8. Topical 9. Thermotherapy 10. BCG vaccine 11. Pentoxifylline 12. Miltefosine 13. Amphotericin B 14. Antifungals For Systemic Use 15. Interferon Gamma 16. Cryotherapy
Interventions:
Fat supplementation of human milk for promoting growth in preterm infants
1. Medium Chain Triglycerides 2. Breast Milk 3. Fat Supplementation
Interventions:
Antibiotic therapy for pelvic inflammatory disease
1. Quinolone -class of antibiotic- 2. Clindamycin 3. Azithromycin 4. Aminoglycoside Antibacterials 5. Nitroimidazole
Interventions:
Stem cell‐based interventions for the prevention of morbidity and mortality following hypoxic‐ischaemic encephalopathy in newborn infants
1. Preventive 2. Stem Cell Therapy
Interventions:
Intravenous immunoglobulin for presumed viral myocarditis in children and adults
1. Immunoglobulins 2. Intravenous 3. Usual Care
Interventions:
Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax
1. Primaquine 2. Chloroquine 3. Artemisinin
Interventions:
Digital contact tracing technologies in epidemics: a rapid review
1. Digital contact tracing
Interventions:
Mobility management to prevent, reduce, or delay driving a car in teenagers
1. Education and guidance on car use
Interventions:
Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
1. Progestogens And Estrogen Systemic Contraceptives, Fixed Combinations 2. Metformin
Interventions:
Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
1. Non-steroidal Anti-inflammatory Drug
Interventions:
Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis
1. Oral 2. Aminosalicylic Acid And Similar Agents
Interventions:
Pancreatic enzyme replacement therapy for people with cystic fibrosis
1. Pancreatic enzyme
Interventions:
Perioperative antibiotics for preventing post‐surgical site infections in solid organ transplant recipients
1. Perioperative 2. Antibiotic Prophylaxis
Interventions:
Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients
1. Glycaemic-lowering agent
Interventions:
Early fortification of human milk versus late fortification to promote growth in preterm infants
1. Early Treatment 2. Fortified Milk 3. Breast Milk
Interventions:
Topical treatment for facial burns
1. Antiseptics 2. Antimicrobials 3. Drug Therapy 4. Complementary Therapy 5. Wound Healing Preparation 6. Topical
Interventions:
Education of family members to support weaning to solids and nutrition in later infancy in term‐born infants
1. Weaning Education
Interventions:
Beta‐blockers for congestive heart failure in children
1. Beta Blocking Agent
Interventions:
Workplace pedometer interventions for increasing physical activity
1. Healthcare programme 2. Workplace 3. Provision Of Pedometer
Interventions:
Interventions for the management of obesity in people with bipolar disorder
1. Non-Pharmacological Interventions
Interventions:
Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis
1. Adjuvant 2. Antibiotic Therapy
Interventions:
Statins for asthma
1. Statins
Interventions:
Head midline position for preventing the occurrence or extension of germinal matrix‐intraventricular haemorrhage in preterm infants
1. Preventive 2. Supine positioning
Interventions:
Psychological interventions for psychosis in adolescents
1. Family Therapy 2. Treatment-adherence therapy 3. Cognitive remediation therapy 4. Psychotherapy 5. Group Psychotherapy 6. Psychoeducation 7. Cognitive Behavioral Therapy
Interventions:
Lamotrigine add‐on therapy for drug‐resistant generalised tonic‐clonic seizures
1. Antiepileptics 2. Lamotrigine
Interventions:
Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia
1. Curtain 2. Phototherapy Of Newborn
Interventions:
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease
1. Sodium Polystyrene Sulfonate 2. Ion exchange resin 3. Calcium Polystyrene Sulfonate Product
Interventions:
Ketogenic diets for drug‐resistant epilepsy
1. Ketogenic diet
Interventions:
Cognitive‐behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour
1. Cognitive Behavioral Therapy
Interventions:
Pitavastatin for lowering lipids
1. Pitavastatin
Interventions:
Low molecular weight heparin for prevention of central venous catheter‐related thrombosis in children
1. Low Molecular Weight Heparin
Interventions:
Ventriculo‐peritoneal shunting devices for hydrocephalus
1. Ventriculoperitoneal Shunt
Interventions:
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis
1. Anti-bacterial agent 2. Biofilm Antimicrobial Susceptibility Test
Interventions:
Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis
1. Antibiotic Therapy
Interventions:
Vitamin K supplementation for cystic fibrosis
1. Vitamin K
Interventions:
Multi‐nutrient fortification of human milk for preterm infants
1. Protein Supplements 2. Energy Supplementation 3. Breast Milk 4. Nutrient supplementation
Interventions:
Effects of total fat intake on body fatness in adults
1. Giving Encouragement To Perform Activity 2. Reduced fat
Interventions:
Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non‐hospitalised term infants
1. Galactagogues 2. Oral
Interventions:
Interventions for congenital talipes equinovarus (clubfoot)
1. Botulinum Toxin 2. Therapeutic Taping 3. Cast Brace 4. Non-Pharmacological Interventions 5. Plaster Cast 6. Surgery 7. Stretching
Interventions:
Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis
1. Detection Of Antimicrobial Substance 2. Antibiotic Therapy
Interventions:
Artificial corneas versus donor corneas for repeat corneal transplants
1. Insertion Of Keratoprosthesis
Interventions:
Alarm interventions for nocturnal enuresis in children
1. Incontinence Alarm
Interventions:
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne
1. Azelaic Acid 2. Salicylic Acid 3. Alpha Hydroxy Acids 4. Nicotinamide 5. Topical 6. Zinc
Interventions:
Corticosteroids as standalone or add‐on treatment for sore throat
1. Corticosteroids - Opthamological and Otological
Interventions:
Inhaled mannitol for cystic fibrosis
1. Mannitol 2. Inhaled
Interventions:
Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long‐term central venous catheters in infants and children
1. Preventive 2. Heparin
Interventions:
Oscillating devices for airway clearance in people with cystic fibrosis
1. Chest Physiotherapy 2. Active Cycle Of Breathing Technique 3. Electroacoustical Airway Secretion-clearing System 4. Oscillating Positive Expiratory Pressure Physiotherapy 5. Autogenic Pulmonary Drainage 6. Physical therapy exercises 7. Chest-oscillation Airway Secretion-clearing System
Interventions:
Tonsillectomy versus tonsillotomy for obstructive sleep‐disordered breathing in children
1. Tonsillectomy 2. Tonsillectomy And Adenoidectomy
Interventions:
Treating progressive disseminated histoplasmosis in people living with HIV
1. Amphotericin B Liposome
Interventions:
Clonazepam add‐on therapy for drug‐resistant epilepsy
1. Clonazepam
Interventions:
Vitamin D, calcium or a combination of vitamin D and calcium for the treatment of nutritional rickets in children
1. Calcium 2. Calcium + Vitamin D
Interventions:
Non‐invasive respiratory support for the management of transient tachypnea of the newborn
1. Nasal 2. Intermittent Positive Pressure Ventilation 3. High Frequency Positive Pressure Ventilation 4. Continuous Positive Airway Pressure Ventilation 5. High Flow Oxygen Nasal Cannula
Interventions:
Interventions for fatigue in inflammatory bowel disease
1. Non-Pharmacological Interventions
Interventions:
Anthelmintic drugs for treating ascariasis
1. Anthelmintic
Interventions:
Omega‐3 fatty acid supplementation for cystic fibrosis
1. N-3 Fatty Acid Supplementation
Interventions:
Rinse‐free hand wash for reducing absenteeism among preschool and school children
1. School 2. Rinse-free hand wash
Interventions:
Agricultural and nutritional education interventions for reducing aflatoxin exposure to improve infant and child growth in low‐ and middle‐income countries
1. Nutrition education 2. Education
Interventions:
EEG for children with complex febrile seizures
1. Electroencephalogram
Interventions:
Clonidine for pain in non‐ventilated infants
1. Preventive 2. Clonidine
Interventions:
Early versus late parenteral nutrition for critically ill term and late preterm infants
1. Early Treatment 2. Parenteral nutrition
Interventions:
Exercise versus no exercise for the occurrence, severity, and duration of acute respiratory infections
1. Physical therapy exercises
Interventions:
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation
1. Antibiotic Therapy
Interventions:
Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)
1. Pre-surgery Evaluation 2. Adenosine 3. Educational Material 4. Selective serotonin re-uptake inhibitor 5. Home Seizure Monitoring System 6. Opiate antagonist 7. General Night Care Of Adult 8. Pillow
Interventions:
Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants
1. Lactoferrin 2. Enteral
Interventions:
Interventions for preventing and managing advanced liver disease in cystic fibrosis
1. Preventive 2. Ligation 3. Transjugular Intrahepatic Portosystemic Shunt 4. Liver transplant 5. Injection Of Sclerosing Agent
Interventions:
Physical therapies for postural abnormalities in people with cystic fibrosis
1. Physiotherapy
Interventions:
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
1. Hydrocortisone 2. Prednisolone
Interventions:
Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
1. Inflation 2. Intermittent Positive Pressure Ventilation 3. Mechanical ventilation
Interventions:
Diaphragm‐triggered non‐invasive respiratory support in preterm infants
1. Mechanical ventilation
Interventions:
Postnatal corticosteroids for transient tachypnoea of the newborn
1. Corticosteroids - Opthamological and Otological
Interventions:
Immunosuppressive agents for treating IgA nephropathy
1. Immunosuppressant
Interventions:
Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
1. Sclerotherapy Of Esophageal Varices
Interventions:
Probiotics for maintenance of remission in ulcerative colitis
1. Probiotics
Interventions:
Home fortification of foods with multiple micronutrient powders for health and nutrition in children under two years of age
1. Vitamin A 2. Fortified food 3. Iron Preparations 4. Home 5. Multiple Micronutrient Powders 6. Zinc 7. Food Additive
Interventions:
Timing of hypertonic saline inhalation for cystic fibrosis
1. Hypertonic saline 2. Nebulizer
Interventions:
Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
1. Preventive 2. Low Dose Heparin Prophylaxis 3. Unfractionated Heparin Therapy 4. Intravenous Bolus
Interventions:
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
1. Echocardiography 2. Intravenous 3. Ibuprofen 4. Infusion Of Drug Or Medicament Via Intravenous Route 5. Oral 6. High Dose
Interventions:
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants
1. Early Treatment 2. Erythropoietin
Interventions:
Surfactant for pulmonary haemorrhage in neonates
1. Endotracheal Administration 2. Lung Surfactants
Interventions:
Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
1. Preventive 2. Immunoglobulins 3. Administration Of Immunoglobulin By Intravenous Route
Interventions:
Paracetamol (acetaminophen) for prevention or treatment of pain in newborns
1. Paracetamol 2. Rectal 3. Intravenous 4. Oral
Interventions:
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
1. Oral 2. Janus kinase inhibitor
Interventions:
Interventions for chronic pruritus of unknown origin
1. Calcineurin inhibitor 2. Peripheral Opioid Receptor Antagonists 3. Capsaicin 4. Biological agent 5. Systemic 6. Botulinum Toxin 7. Cannabinoids 8. Salicylic Acid 9. Phosphodiesterase 4 inhibitor 10. Antidepressants 11. Antihistamines For Topical Use 12. Emollient 13. Thalidomide 14. Aprepitant 15. Local Cooling Therapy 16. Amitriptyline 17. Complementary Therapy 18. Monoclonal Antibodies 19. Topical 20. Anesthetics 21. Anticonvulsants 22. Ketamine 23. Corticosteroids - Opthamological and Otological 24. Plant Alkaloids And Other Natural Products 25. Antihistamines For Systemic Use 26. Ondansetron 27. Phototherapy Of Skin
Interventions:
Probiotics for people with cystic fibrosis
1. Probiotics 2. Oral 3. Prebiotics
Interventions:
Improving vaccination uptake among adolescents
1. Healthcare costs subsidization 2. Healthcare access 3. School-based immunization programme 4. Immunization campaign 5. Immunization Education
Interventions:
Hypertonic saline versus other intracranial pressure–lowering agents for people with acute traumatic brain injury
1. Hypertonic saline
Interventions:
Anti‐inflammatory medications for obstructive sleep apnoea in children
1. Glucocorticoids - Systemic 2. Ketotifen 3. Cromolyn Sodium 4. Leukotriene Receptor Antagonists
Interventions:
Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
1. Sclerotherapy Of Esophageal Varices
Interventions:
Topical antiseptics for chronic suppurative otitis media
1. Antiseptics 2. Topical 3. Antibiotic Therapy
Interventions:
Drug treatment for spinal muscular atrophy types II and III
1. Drug Therapy
Interventions:
Antibiotics versus topical antiseptics for chronic suppurative otitis media
1. Topical 2. Systemic 3. Antibiotic Therapy
Interventions:
Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors
1. Participative Approach 2. Physical activity 3. Primary Caregiver 4. Physical Activity Assessment 5. Feeding and dietary regime
Interventions:
Topical antibiotics for chronic suppurative otitis media
1. Quinolone Antibacterials 2. Topical 3. Oral 4. Antibiotic Therapy
Interventions:
Decompressive craniectomy for the treatment of high intracranial pressure in closed traumatic brain injury
1. Decompression Of Cranial Nerve
Interventions:
Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)
1. Tonsillectomy 2. Tonsillotomy 3. Tonsillectomy And Adenoidectomy
Interventions:
Racecadotril for acute diarrhoea in children
1. Racecadotril 2. Oral
Interventions:
Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis
1. Inactivated poliovirus vaccine 2. Intradermal 3. Low Dose
Interventions:
Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis
1. Preventive 2. Antibiotic Therapy
Interventions:
Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice
1. Antibiotic Prophylaxis
Interventions:
Interventions for managing halitosis
1. Chewing Gum 2. Mouthwash 3. Toothbrushing 4. Tongue Scraper, Reusable
Interventions:
Drug treatment for spinal muscular atrophy type I
1. Drug Therapy
Interventions:
Iron therapy for preoperative anaemia
1. Parenteral 2. Iron Preparations 3. Oral
Interventions:
Primary closure versus delayed or no closure for traumatic wounds due to mammalian bite
1. Closure By Suture
Interventions:
Corticosteroids for treating sepsis in children and adults
1. Corticosteroids - Opthamological and Otological
Interventions:
Beginning reading interventions for children and adolescents with intellectual disability
1. Reading
Interventions:
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
1. Oral Poliovirus Vaccine 2. Inactivated poliovirus vaccine 3. Sequential injection
Interventions:
Parent training programmes for managing infantile colic
1. Parent Education: Infant